(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are FAT Brands, Wipro Limited, and Public Service Enterprise Group.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 FAT Brands (FAT) 6.63 5.32% 2022-05-04 04:17:20
2 Wipro Limited (WIT) 6.73 4.67% 2022-05-04 07:20:10
3 Public Service Enterprise Group (PEG) 71.37 4.19% 2022-05-04 04:41:14
4 ImmunoGen (IMGN) 5.26 4.16% 2022-05-04 04:12:30
5 FibroGen (FGEN) 10.03 3.19% 2022-05-04 04:11:23
6 Upland Software (UPLD) 15.06 2.87% 2022-05-04 06:45:16
7 Banco Bradesco (BBD) 3.70 2.78% 2022-05-04 07:10:12
8 Camelot Capital Partners, LLC (BBD) 3.70 2.78% 2022-05-04 07:10:12
9 Banco Bradesco (BBD) 3.70 2.78% 2022-05-04 07:10:12
10 Camelot Capital Partners, LLC (BBD) 3.70 2.78% 2022-05-04 07:10:12

The three most active and biggest losers today are Fresenius Medical Care AG, ICICI Bank, and Teva Pharmaceutical.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 Fresenius Medical Care AG (FMS) 30.31 -4.2% 2022-05-04 07:21:32
2 ICICI Bank (IBN) 18.96 -2.12% 2022-05-04 07:01:27
3 Teva Pharmaceutical (TEVA) 8.44 -1.86% 2022-05-04 07:18:55
4 Deutsche Bank (DB) 10.31 -1.15% 2022-05-04 07:20:37
5 TherapeuticsMD (TXMD) 0.19 -1.02% 2022-05-04 07:33:16
6 Banco Santander (SAN) 2.93 -1.01% 2022-05-04 07:33:17
7 Sundial Growers (SNDL) 0.48 -0.72% 2022-05-04 07:32:49
8 Lloyds Banking Group (LYG) 2.27 -0.66% 2022-05-04 07:30:31
9 Bionano Genomics (BNGO) 1.75 -0.57% 2022-05-04 07:01:47
10 Broadcom (AVGOP) 1813.00 -0.56% 2022-05-04 07:31:51

Most Active Premarket Winners today

1. FAT Brands (FAT) – Premarket: 5.32%

NASDAQ ended the session with FAT Brands jumping 7.98% to $6.30 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.22% to $12,563.76, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for FAT Brands is 7572, 68.08% below its average volume of 23726.

FAT Brands’s last close was $6.30, 60.6% below its 52-week high of $15.99.

FAT Brands’s Revenue

Year-on-year quarterly revenue growth grew by 627.8%, now sitting on 51.19M for the twelve trailing months.

Volatility

FAT Brands’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.01%, a negative 0.65%, and a positive 3.33%, respectively.

FAT Brands’s highest amplitude of average volatility was 2.60% (last week), 3.98% (last month), and 3.33% (last quarter), respectively.

FAT Brands’s Stock Yearly Top and Bottom Value

FAT Brands’s stock is valued at $6.30 at 08:34 EST, way below its 52-week high of $15.99 and way higher than its 52-week low of $5.47.

FAT Brands’s Moving Average

FAT Brands’s value is way below its 50-day moving average of $7.19 and way below its 200-day moving average of $9.68.

More news about FAT Brands.

2. Wipro Limited (WIT) – Premarket: 4.67%

NYSE ended the session with Wipro Limited jumping 0.08% to $6.43 on Wednesday, after four consecutive sessions in a row of losses. NYSE rose 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Wipro Limited is 1931060, 39.13% below its average volume of 3172870.

Wipro Limited’s last close was $7.54, 24.3% below its 52-week high of $9.96.

Wipro Limited’s Revenue

Year-on-year quarterly revenue growth grew by 29.6%, now sitting on 744.79B for the twelve trailing months.

Wipro Limited’s Stock Yearly Top and Bottom Value

Wipro Limited’s stock is valued at $6.43 at 08:34 EST, under its 52-week low of $6.44.

Wipro Limited’s Moving Average

Wipro Limited’s value is way below its 50-day moving average of $7.43 and way under its 200-day moving average of $8.47.

More news about Wipro Limited.

3. Public Service Enterprise Group (PEG) – Premarket: 4.19%

NYSE ended the session with Public Service Enterprise Group falling 0.5% to $68.50 on Wednesday while NYSE jumped 0.77% to $15,729.53.

Volume

Today’s last reported volume for Public Service Enterprise Group is 2512200, 8.94% below its average volume of 2758900.

Public Service Enterprise Group’s last close was $68.50, 4.85% higher than its 52-week high of $65.33.

Public Service Enterprise Group’s Sales

Public Service Enterprise Group’s sales growth is 11.8% for the present quarter and 9.4% for the next.

Public Service Enterprise Group’s Revenue

Year-on-year quarterly revenue growth declined by 19.7%, now sitting on 9.07B for the twelve trailing months.

Volatility

Public Service Enterprise Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.78%, a negative 0.06%, and a positive 1.04%, respectively.

Public Service Enterprise Group’s highest amplitude of average volatility was 1.44% (last week), 1.12% (last month), and 1.04% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Public Service Enterprise Group’s stock is considered to be overbought (>=80).

Public Service Enterprise Group’s Stock Yearly Top and Bottom Value

Public Service Enterprise Group’s stock is valued at $68.50 at 08:34 EST, higher than its 52-week high of $65.33.

Public Service Enterprise Group’s Moving Average

Public Service Enterprise Group’s worth is above its 50-day moving average of $62.84 and way above its 200-day moving average of $61.95.

More news about Public Service Enterprise Group.

4. ImmunoGen (IMGN) – Premarket: 4.16%

NASDAQ ended the session with ImmunoGen dropping 0.57% to $5.05 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.22% to $12,563.76, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for ImmunoGen is 1234200, 65.89% below its average volume of 3618400.

ImmunoGen’s last close was $5.05, 38.56% under its 52-week high of $8.22.

ImmunoGen’s Sales

ImmunoGen’s sales growth is a negative 70.1% for the present quarter and a decline by 39.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 1262.5% and a negative 35.3%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth declined by 49.4%, now sitting on 127.66M for the twelve trailing months.

Volatility

ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.25%, a negative 0.51%, and a positive 3.76%, respectively.

ImmunoGen’s highest amplitude of average volatility was 2.17% (last week), 2.55% (last month), and 3.76% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ImmunoGen’s stock is considered to be oversold (<=20).

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $5.05 at 08:34 EST, way below its 52-week high of $8.22 and way higher than its 52-week low of $3.83.

ImmunoGen’s Moving Average

ImmunoGen’s worth is under its 50-day moving average of $5.11 and way under its 200-day moving average of $5.76.

More news about ImmunoGen.

5. FibroGen (FGEN) – Premarket: 3.19%

NASDAQ ended the session with FibroGen jumping 0.99% to $9.72 on Wednesday while NASDAQ jumped 0.22% to $12,563.76.

Volume

Today’s last reported volume for FibroGen is 263582, 64.36% below its average volume of 739740.

FibroGen’s last close was $9.72, 67.73% under its 52-week high of $30.12.

FibroGen’s Sales

FibroGen’s sales growth is a negative 29.8% for the current quarter and a decline by 2.5% for the next. The company’s growth estimates for the ongoing quarter is a negative 4.7% and positive 15.4% for the next.

FibroGen’s Revenue

Year-on-year quarterly revenue growth grew by 254.2%, now sitting on 283.76M for the twelve trailing months.

Volatility

FibroGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.43%, a negative 1.70%, and a positive 3.03%, respectively.

FibroGen’s highest amplitude of average volatility was 2.67% (last week), 2.95% (last month), and 3.03% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

FibroGen’s stock is considered to be oversold (<=20).

FibroGen’s Stock Yearly Top and Bottom Value

FibroGen’s stock is valued at $9.72 at 08:34 EST, way under its 52-week high of $30.12 and above its 52-week low of $9.26.

FibroGen’s Moving Average

FibroGen’s value is way under its 50-day moving average of $12.45 and way below its 200-day moving average of $12.75.

More news about FibroGen.

6. Upland Software (UPLD) – Premarket: 2.87%

NASDAQ ended the session with Upland Software dropping 2.2% to $14.64 on Wednesday while NASDAQ rose 0.22% to $12,563.76.

Volume

Today’s last reported volume for Upland Software is 114441, 56.11% below its average volume of 260748.

Upland Software’s last close was $14.64, 70.78% under its 52-week high of $50.11.

Upland Software’s Sales

Upland Software’s sales growth is a negative 3.6% for the current quarter and 2.7% for the next. The company’s growth estimates for the current quarter and the next is a negative 24.6% and a negative 30%, respectively.

Upland Software’s Revenue

Year-on-year quarterly revenue growth grew by 2.5%, now sitting on 304.53M for the twelve trailing months.

Volatility

Upland Software’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.82%, a negative 1.05%, and a positive 2.67%, respectively.

Upland Software’s highest amplitude of average volatility was 2.11% (last week), 2.49% (last month), and 2.67% (last quarter), respectively.

Upland Software’s Stock Yearly Top and Bottom Value

Upland Software’s stock is valued at $14.64 at 08:34 EST, way under its 52-week high of $50.11 and above its 52-week low of $14.17.

Upland Software’s Moving Average

Upland Software’s worth is way below its 50-day moving average of $16.83 and way under its 200-day moving average of $25.40.

More news about Upland Software.

7. Banco Bradesco (BBD) – Premarket: 2.78%

NYSE ended the session with Banco Bradesco rising 3.44% to $3.60 on Wednesday, after two sequential sessions in a row of losses. NYSE rose 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Banco Bradesco is 36664000, 4.28% below its average volume of 38307000.

Banco Bradesco’s last close was $4.03, 29.3% below its 52-week high of $5.70.

Banco Bradesco’s Sales

Banco Bradesco’s sales growth is 4% for the current quarter and a decline by 11.7% for the next.

Banco Bradesco’s Revenue

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 90.82B for the twelve trailing months.

Banco Bradesco’s Stock Yearly Top and Bottom Value

Banco Bradesco’s stock is valued at $3.60 at 08:34 EST, way below its 52-week high of $5.70 and way above its 52-week low of $3.25.

Banco Bradesco’s Moving Average

Banco Bradesco’s value is way under its 50-day moving average of $4.19 and way below its 200-day moving average of $4.00.

More news about Banco Bradesco.

8. Camelot Capital Partners, LLC (BBD) – Premarket: 2.78%

NYSE ended the session with Camelot Capital Partners, LLC jumping 3.44% to $3.60 on Wednesday while NYSE rose 0.77% to $15,729.53.

Volume

Today’s last reported volume for Camelot Capital Partners, LLC is 36664000, 4.28% below its average volume of 38307000.

Camelot Capital Partners, LLC’s last close was $4.03, 29.3% below its 52-week high of $5.70.

Camelot Capital Partners, LLC’s Sales

Camelot Capital Partners, LLC’s sales growth is 4% for the present quarter and a decline by 11.7% for the next.

Camelot Capital Partners, LLC’s Revenue

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 90.82B for the twelve trailing months.

Camelot Capital Partners, LLC’s Stock Yearly Top and Bottom Value

Camelot Capital Partners, LLC’s stock is valued at $3.60 at 08:34 EST, way below its 52-week high of $5.70 and way higher than its 52-week low of $3.25.

Camelot Capital Partners, LLC’s Moving Average

Camelot Capital Partners, LLC’s value is way below its 50-day moving average of $4.19 and way below its 200-day moving average of $4.00.

More news about Camelot Capital Partners, LLC.

9. Banco Bradesco (BBD) – Premarket: 2.78%

NYSE ended the session with Banco Bradesco jumping 3.44% to $3.60 on Wednesday, after two sequential sessions in a row of losses. NYSE jumped 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Banco Bradesco is 36664000, 4.28% below its average volume of 38307000.

Banco Bradesco’s last close was $4.03, 29.3% below its 52-week high of $5.70.

Banco Bradesco’s Sales

Banco Bradesco’s sales growth is 4% for the current quarter and a decline by 11.7% for the next.

Banco Bradesco’s Revenue

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 90.82B for the twelve trailing months.

Banco Bradesco’s Stock Yearly Top and Bottom Value

Banco Bradesco’s stock is valued at $3.60 at 08:34 EST, way under its 52-week high of $5.70 and way above its 52-week low of $3.25.

Banco Bradesco’s Moving Average

Banco Bradesco’s worth is way below its 50-day moving average of $4.19 and way under its 200-day moving average of $4.00.

More news about Banco Bradesco.

10. Camelot Capital Partners, LLC (BBD) – Premarket: 2.78%

NYSE ended the session with Camelot Capital Partners, LLC rising 3.44% to $3.60 on Wednesday, after two consecutive sessions in a row of losses. NYSE rose 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Camelot Capital Partners, LLC is 36664000, 4.28% below its average volume of 38307000.

Camelot Capital Partners, LLC’s last close was $4.03, 29.3% below its 52-week high of $5.70.

Camelot Capital Partners, LLC’s Sales

Camelot Capital Partners, LLC’s sales growth is 4% for the current quarter and a decline by 11.7% for the next.

Camelot Capital Partners, LLC’s Revenue

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 90.82B for the twelve trailing months.

Camelot Capital Partners, LLC’s Stock Yearly Top and Bottom Value

Camelot Capital Partners, LLC’s stock is valued at $3.60 at 08:34 EST, way below its 52-week high of $5.70 and way above its 52-week low of $3.25.

Camelot Capital Partners, LLC’s Moving Average

Camelot Capital Partners, LLC’s value is way below its 50-day moving average of $4.19 and way under its 200-day moving average of $4.00.

More news about Camelot Capital Partners, LLC.

Most Active Premarket Losers Today

1. Fresenius Medical Care AG (FMS) – Premarket: -4.2%

NYSE ended the session with Fresenius Medical Care AG rising 2.53% to $31.64 on Wednesday, after two successive sessions in a row of gains. NYSE rose 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 378786, 28.11% below its average volume of 526911.

Fresenius Medical Care AG’s last close was $31.64, 26.98% under its 52-week high of $43.33.

Fresenius Medical Care AG’s Sales

Fresenius Medical Care AG’s sales growth is a negative 5% for the ongoing quarter and 27.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 26% and a negative 24.7%, respectively.

Fresenius Medical Care AG’s Revenue

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.

Volatility

Fresenius Medical Care AG’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.72%, a negative 0.50%, and a positive 1.59%, respectively.

Fresenius Medical Care AG’s highest amplitude of average volatility was 1.21% (last week), 1.27% (last month), and 1.59% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fresenius Medical Care AG’s stock is considered to be overbought (>=80).

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $31.64 at 08:34 EST, way under its 52-week high of $43.33 and higher than its 52-week low of $29.71.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s worth is below its 50-day moving average of $33.36 and way below its 200-day moving average of $37.59.

More news about Fresenius Medical Care AG.

2. ICICI Bank (IBN) – Premarket: -2.12%

NYSE ended the session with ICICI Bank jumping 0.94% to $19.37 on Wednesday, after two consecutive sessions in a row of losses. NYSE jumped 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for ICICI Bank is 3164430, 74.95% below its average volume of 12635800.

ICICI Bank’s last close was $17.61, 21.17% under its 52-week high of $22.34.

The company’s growth estimates for the present quarter and the next is 4.8% and 31.6%, respectively.

ICICI Bank’s Revenue

Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 1.01T for the twelve trailing months.

ICICI Bank’s Stock Yearly Top and Bottom Value

ICICI Bank’s stock is valued at $19.37 at 08:34 EST, way below its 52-week high of $22.34 and way above its 52-week low of $15.74.

ICICI Bank’s Moving Average

ICICI Bank’s value is above its 50-day moving average of $18.96 and under its 200-day moving average of $19.58.

More news about ICICI Bank.

3. Teva Pharmaceutical (TEVA) – Premarket: -1.86%

NYSE ended the session with Teva Pharmaceutical jumping 0.76% to $8.60 on Wednesday while NYSE jumped 0.77% to $15,729.53.

Volume

Today’s last reported volume for Teva Pharmaceutical is 10055200, 14.59% above its average volume of 8774810.

Teva Pharmaceutical’s last close was $7.48, 35.24% under its 52-week high of $11.55.

Teva Pharmaceutical’s Sales

Teva Pharmaceutical’s sales growth is a negative 3.7% for the present quarter and a decline by 1.6% for the next.

Teva Pharmaceutical’s Revenue

Year-on-year quarterly revenue growth declined by 2.3%, now sitting on 16.23B for the twelve trailing months.

Teva Pharmaceutical’s Stock Yearly Top and Bottom Value

Teva Pharmaceutical’s stock is valued at $8.60 at 08:34 EST, way below its 52-week high of $11.55 and way above its 52-week low of $7.24.

Teva Pharmaceutical’s Moving Average

Teva Pharmaceutical’s value is below its 50-day moving average of $8.70 and under its 200-day moving average of $8.97.

More news about Teva Pharmaceutical.

4. Deutsche Bank (DB) – Premarket: -1.15%

NYSE ended the session with Deutsche Bank rising 3.47% to $10.43 on Wednesday, after five consecutive sessions in a row of gains. NYSE jumped 0.77% to $15,729.53, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Volume

Today’s last reported volume for Deutsche Bank is 4934440, 37.25% below its average volume of 7864500.

Deutsche Bank’s last close was $10.43, 32.01% below its 52-week high of $15.34.

The company’s growth estimates for the present quarter is 200% and a drop 76.2% for the next.

Deutsche Bank’s Revenue

Year-on-year quarterly revenue growth grew by 3.5%, now sitting on 24.79B for the twelve trailing months.

Volatility

Deutsche Bank’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.18%, a negative 1.46%, and a positive 3.29%, respectively.

Deutsche Bank’s highest amplitude of average volatility was 2.25% (last week), 2.60% (last month), and 3.29% (last quarter), respectively.

Deutsche Bank’s Stock Yearly Top and Bottom Value

Deutsche Bank’s stock is valued at $10.43 at 08:34 EST, way below its 52-week high of $15.34 and higher than its 52-week low of $10.08.

Deutsche Bank’s Moving Average

Deutsche Bank’s worth is way under its 50-day moving average of $12.83 and way under its 200-day moving average of $12.95.

More news about Deutsche Bank.

5. TherapeuticsMD (TXMD) – Premarket: -1.02%

NASDAQ ended the session with TherapeuticsMD rising 1.99% to $0.19 on Wednesday, after five sequential sessions in a row of losses. NASDAQ rose 0.22% to $12,563.76, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for TherapeuticsMD is 4932080, 33.26% below its average volume of 7390090.

TherapeuticsMD’s last close was $0.19, 93.2% under its 52-week high of $2.75.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.

Volatility

TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 4.73%, a negative 3.50%, and a positive 6.41%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 4.73% (last week), 4.33% (last month), and 6.41% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.19 at 08:34 EST, way below its 52-week low of $0.37.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way below its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.

More news about TherapeuticsMD.

6. Banco Santander (SAN) – Premarket: -1.01%

NYSE ended the session with Banco Santander rising 2.96% to $2.96 on Wednesday while NYSE rose 0.77% to $15,729.53.

Volume

Today’s last reported volume for Banco Santander is 5857850, 23.27% below its average volume of 7634460.

Banco Santander’s last close was $3.07, 29.91% below its 52-week high of $4.38.

Banco Santander’s Revenue

Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 36.7B for the twelve trailing months.

Banco Santander’s Stock Yearly Top and Bottom Value

Banco Santander’s stock is valued at $2.96 at 08:34 EST, way under its 52-week high of $4.38 and higher than its 52-week low of $2.77.

Banco Santander’s Moving Average

Banco Santander’s worth is way below its 50-day moving average of $3.34 and way under its 200-day moving average of $3.53.

Previous days news about Banco Santander

  • Banco santander sets strict guardrails for potential Mexico deal. According to Bloomberg Quint on Monday, 2 May, "Ana Botin, the chair of Banco Santander SA, called Mexico a "growth engine" for the bank but cautioned that the lender would only seek to buy Citigroup Inc.’s retail business in the country if certain requirements are met."

More news about Banco Santander.

7. Sundial Growers (SNDL) – Premarket: -0.72%

NASDAQ ended the session with Sundial Growers jumping 0.6% to $0.49 on Wednesday, after five sequential sessions in a row of gains. NASDAQ rose 0.22% to $12,563.76, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Sundial Growers is 53609900, 47.98% below its average volume of 103063000.

Sundial Growers’s last close was $0.49, 67.45% below its 52-week high of $1.49.

Sundial Growers’s Sales

Sundial Growers’s sales growth is 129.8% for the current quarter and 1461.8% for the next. The company’s growth estimates for the present quarter and the next is 100% and 100%, respectively.

Sundial Growers’s Revenue

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 47.26M for the twelve trailing months.

Volatility

Sundial Growers’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.06%, a negative 2.03%, and a positive 4.76%, respectively.

Sundial Growers’s highest amplitude of average volatility was 4.97% (last week), 4.57% (last month), and 4.76% (last quarter), respectively.

Sundial Growers’s Stock Yearly Top and Bottom Value

Sundial Growers’s stock is valued at $0.49 at 08:34 EST, way below its 52-week high of $1.49 and way above its 52-week low of $0.40.

Sundial Growers’s Moving Average

Sundial Growers’s worth is way below its 50-day moving average of $0.56 and way below its 200-day moving average of $0.64.

More news about Sundial Growers.

8. Lloyds Banking Group (LYG) – Premarket: -0.66%

NYSE ended the session with Lloyds Banking Group jumping 2.23% to $2.29 on Wednesday while NYSE rose 0.77% to $15,729.53.

Volume

Today’s last reported volume for Lloyds Banking Group is 15287500, 13.83% above its average volume of 13430100.

Lloyds Banking Group’s last close was $2.31, 23% below its 52-week high of $3.00.

Lloyds Banking Group’s Revenue

Year-on-year quarterly revenue growth grew by 29.7%, now sitting on 16.03B for the twelve trailing months.

Lloyds Banking Group’s Stock Yearly Top and Bottom Value

Lloyds Banking Group’s stock is valued at $2.29 at 08:34 EST, way under its 52-week high of $3.00 and above its 52-week low of $2.09.

Lloyds Banking Group’s Moving Average

Lloyds Banking Group’s worth is below its 50-day moving average of $2.48 and under its 200-day moving average of $2.54.

More news about Lloyds Banking Group.

9. Bionano Genomics (BNGO) – Premarket: -0.57%

NASDAQ ended the session with Bionano Genomics jumping 1.73% to $1.76 on Wednesday while NASDAQ rose 0.22% to $12,563.76.

Volume

Today’s last reported volume for Bionano Genomics is 4222560, 41.59% below its average volume of 7229660.

Bionano Genomics’s last close was $1.76, 80.7% below its 52-week high of $9.12.

Volatility

Bionano Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 6.13%, a negative 2.95%, and a positive 4.88%, respectively.

Bionano Genomics’s highest amplitude of average volatility was 6.13% (last week), 4.86% (last month), and 4.88% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Bionano Genomics’s stock is considered to be oversold (<=20).

Bionano Genomics’s Stock Yearly Top and Bottom Value

Bionano Genomics’s stock is valued at $1.76 at 08:34 EST, way below its 52-week high of $9.12 and way above its 52-week low of $1.50.

Bionano Genomics’s Moving Average

Bionano Genomics’s worth is way below its 50-day moving average of $2.09 and way under its 200-day moving average of $3.88.

More news about Bionano Genomics.

10. Broadcom (AVGOP) – Premarket: -0.56%

NASDAQ ended the session with Broadcom jumping 3% to $1,823.14 on Wednesday while NASDAQ rose 0.22% to $12,563.76.

Volume

Today’s last reported volume for Broadcom is 7306, 61.15% below its average volume of 18810.

Broadcom’s last close was $1,823.14, 13.16% under its 52-week high of $2,099.51.

Broadcom’s Revenue

Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 27.45B for the twelve trailing months.

Volatility

Broadcom’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.13%, a negative 0.67%, and a positive 1.60%, respectively.

Broadcom’s highest amplitude of average volatility was 2.56% (last week), 1.80% (last month), and 1.60% (last quarter), respectively.

Broadcom’s Stock Yearly Top and Bottom Value

Broadcom’s stock is valued at $1,823.14 at 08:34 EST, way under its 52-week high of $2,099.51 and way above its 52-week low of $1,351.03.

Broadcom’s Moving Average

Broadcom’s value is under its 50-day moving average of $1,853.76 and higher than its 200-day moving average of $1,739.98.

More news about Broadcom.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here